Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.
Ultrasonographic nerve enlargement of the median and ulnar nerves and the cervical nerve roots in patients with demyelinating Charcot-Marie-Tooth disease: distinction from patients with chronic inflammatory demyelinating polyneuropathy.
Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism.
Teriflunomide for the treatment of multiple sclerosis.
Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series.
Clinical Outcomes Following Surgical Management of Coexistent Cervical Stenosis and Multiple Sclerosis: A Cohort Controlled Analysis.
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Tumefactive demyelinating lesions: Characteristics of individual lesions, individual patients, or a unique disease entity?
Multiple sclerosis severity and concern about falling: Physical, cognitive and psychological mediating factors.
[Tumefactive multiple sclerosis and connexin].
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells.
Multiple sclerosis and fatigue: A review on the contribution of inflammation and immune-mediated neurodegeneration.
The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases.
Author response.
Effects of transcranial random noise stimulation (tRNS) on affect, pain and attention in multiple sclerosis.
Concise review: Stem cell trials using companion animal disease models.
Altered functional connectivity and performance variability in relapsing-remitting multiple sclerosis.
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.
Analysis of macular OCT images using deformable registration.
Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis.
The Role of Pregnancy-Associated Hormones in the Development and Function of Regulatory B Cells.
Ischemic Retinal Vasculitis and Its Management.
Abnormal myelin and axonal integrity in recently diagnosed patients with obstructive sleep apnea.
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.
Snake bite-induced leucoencephalopathy.
Pages
« first
‹ previous
…
522
523
524
525
526
527
528
529
530
…
next ›
last »